medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2009, Número 2

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2009; 7 (2)


Necrobiosis lipoídica

Cepeda VR, Salas AJ

Idioma: Español
Referencias bibliográficas: 102
Paginas: 132-135
Archivo PDF: 1071.29 Kb.


FRAGMENTO

Caso clínico

Es un paciente femenino de 36 años de edad, residente de Monterrey, Nuevo León, con diabetes mellitus tipo I, de siete años de evolución, en tratamiento con 30 UI de insulina subcutánea.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Houda H, Soumaya Y, Kahena J, Mohamed RD, Nejib D. “Per fo - rating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: A new case reported”. Dermatol Online J 2008; 14 (supl. 7): 11.

  2. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 152: “Diabetes Mellitus and Other Endocrine Diseases”, consultado el 12 de febrero de 2009 en http://0-www. accessmedicine.com.millenium.itesm.mx:80/content.aspx?aID= 2991346.

  3. Körber A, Dissemond J. “Necrobiosis lipidica diabeticorum”. CMAJ 2007; 177(12): 1498.

  4. Gökdemir G, Sakız D, Kö lü A. “Pyoderma gangrenosum-like presentation of ulcerative necrobiosis lipoidica: Diagnostic and therapeutic challenge”. J Turk Acad Dermatol 2008; 2(1): 82101cpdf.

  5. Arenas R. “Necrobiosis lipoídica”. Atlas. Dermatología, diagnóstico y tratamiento. 3a ed. México, 2005: pp. 195-197.

  6. Imakado S, Satomi H, Iskikawa M, Iwata M, Tsubouchi Y, Otsuka F. “Diffuse necrobiosis lipoidica diabeticorum associated with noninsulin dependent diabetes mellitus”. Clin Exp Dermatol 1998; 23(supl. 6): 271-273.

  7. Wee SA, Possick P. “Necrobiosis lipoidica”. Dermatol Online J 2004; 10(supl. 3): 18.

  8. O’Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. “Necrobiosis lipoidica: Only a minority of patients have diabetes mellitus”. Br J Dermatol 1999; 140(supl. 2): 283-286.

  9. Dandona P, Freedman D, Barter S, Majew BB, Rhodes EL, Waston B. “Glycosylated haemoglobin in patients with necrobiosis lipoidica and granuloma annulare”. Clin Exp Dermatol 1981; 6(3): 299-302.

  10. Cohen O, Yaniv R, Karasik A, Trau H. “Necrobiosis lipoidica and diabetic control revisited”. Med Hypotheses 1996; 46(supl. 4): 348-350.

  11. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L. “Successful treatment of necrobiosis lipoidica with antimalarial agents”. Arch Dermatol 2008; 144(1): 118-119.

  12. Ullman S. Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  13. Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, Rendell M. “Skin blood flow in necrobiosis lipoidica diabeticorum”. Int J Dermatol 2008; 47(4): 354-358.

  14. Wake N, Fang JC. “Necrobiosis lipoidica diabeticorum”. Engl J Med 2006; 355: e20.

  15. Fourati M, Marrak H, Fenniche S, Zakraoui H, Zghal M, Khayat O et al. “Necrobiosis lipoidica. Report of 4 cases and review of the literature”. Tunis Med 2003; 81(supl.6): 428-431.

  16. Palamaras I, Kench P, Thomson P, Al-Dulaimi AH, Stevens HP, RoblesW. “An unusual presentation of a common disease”. Dermatol Online J 14: 4.

  17. Requena L, Yus ES. “Panniculitis. Part I. Mostly septal panniculitis”. J Am Acad Dermatol 2001; 45: 163-183, 184-186.

  18. Ullman S, Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  19. Fernandez-Flores A. “Necrobiosis lipoidica and cutaneous anaesthesia: Immunohistochemical study of neural fibres”. Folia Neuropathol 2008; 46(2): 154-157.

  20. Abdulla FR, Sheth PB. “A case of perforating necrobiosis lipoidica in an African American female”. Dermatol Online J 2008; 14(supl. 7): 10.

  21. Falanga V, Eaglstein WH. “Leg and foot ulcers: A clinician’s guide”. 1995; 49-52.

  22. Salomón HJ, Vila FJ, Sales MJM. “Úlceras de las EEII. Diagnóstico diferencial y guía de tratamiento”. Anales de Cirugía Cardiaca y Vascular 2001; 7(4): 253-270.

  23. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. “The clinical spectrum of lipodermatosclerosis”. J Am Acad Dermatol 1993; 28(4): 623-627.

  24. 24.Wee SA, Shupack JL. “Necrobiotic xanthogranuloma”. Dermatol Online J 2005; 11(4): 24.

  25. Gibson LE, Reizner GT, Winkelmann RK. “Necrobiosis lipoidica diabeticorum with cholesterol clefts in the differential diagnosis of necrobiotic xanthogranuloma”. J Cutan Pathol 1988; 15: 18-21.

  26. 26.Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 166: “Erythema Elevatum Diutinum”, consultado el 12 de febrero de 2009 en: http://0-www.accessmedicine.com. millenium.itesm.mx:80/content.aspx?aID=2967488.

  27. Macaron NC, Cohen C, Chen SC, Arbiser JL. “Gli-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum”. Arch Dermatol 2005; 141: 259-262.

  28. Nguyen K, Washenik K, Shupack J. “Necrobiosis lipoidica diabeticorum treated with chloroquine”. J Am Acad Dermatol 2002; 46(2 supl.): S34-S36.

  29. 29.Kreuter A, Knierim C, Stücker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T. “Fumaric acid esters in necrobiosis lipoidica: Results of a prospective noncontrolled study”. Br J Dermatol 2005; 153(4): 802-807.

  30. Cawley EP, Dingman RO. “Necrobiosis lipoidica diabeticorum: Its surgical treatment”. AMA Arch Derm Syphilol 1951; 63(6): 764-767.

  31. Moreno-Arias GA, Camps-Fresneda A. “Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser”. J Cosmet Laser Ther 2001; 3: 143-146.

  32. Darvay A, Acland KM, Russell-Jones R. “Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin”. Br J Dermatol 1999; 141(4): 725-727.

  33. Remes K, Rönnemaa T. “Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment”. J Diabetes Complications 1999; 13(2): 115-118.

  34. De Rie MA, Sommer A, Hoekzema R, Neumann HA. “Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A”. Br J Dermatol 2002; 147(4): 743-747.

  35. Houda H, Soumaya Y, Kahena J, Mohamed RD, Nejib D. “Per fo - rating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: A new case reported”. Dermatol Online J 2008; 14 (supl. 7): 11.

  36. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 152: “Diabetes Mellitus and Other Endocrine Diseases”, consultado el 12 de febrero de 2009 en http://0-www. accessmedicine.com.millenium.itesm.mx:80/content.aspx?aID= 2991346.

  37. Körber A, Dissemond J. “Necrobiosis lipidica diabeticorum”. CMAJ 2007; 177(12): 1498.

  38. Gökdemir G, Sakız D, Kö lü A. “Pyoderma gangrenosum-like presentation of ulcerative necrobiosis lipoidica: Diagnostic and therapeutic challenge”. J Turk Acad Dermatol 2008; 2(1): 82101cpdf.

  39. Arenas R. “Necrobiosis lipoídica”. Atlas. Dermatología, diagnóstico y tratamiento. 3a ed. México, 2005: pp. 195-197.

  40. Imakado S, Satomi H, Iskikawa M, Iwata M, Tsubouchi Y, Otsuka F. “Diffuse necrobiosis lipoidica diabeticorum associated with noninsulin dependent diabetes mellitus”. Clin Exp Dermatol 1998; 23(supl. 6): 271-273.

  41. Wee SA, Possick P. “Necrobiosis lipoidica”. Dermatol Online J 2004; 10(supl. 3): 18.

  42. O’Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. “Necrobiosis lipoidica: Only a minority of patients have diabetes mellitus”. Br J Dermatol 1999; 140(supl. 2): 283-286.

  43. Dandona P, Freedman D, Barter S, Majew BB, Rhodes EL, Waston B. “Glycosylated haemoglobin in patients with necrobiosis lipoidica and granuloma annulare”. Clin Exp Dermatol 1981; 6(3): 299-302.

  44. Cohen O, Yaniv R, Karasik A, Trau H. “Necrobiosis lipoidica and diabetic control revisited”. Med Hypotheses 1996; 46(supl. 4): 348-350.

  45. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L. “Successful treatment of necrobiosis lipoidica with antimalarial agents”. Arch Dermatol 2008; 144(1): 118-119.

  46. Ullman S. Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  47. Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, Rendell M. “Skin blood flow in necrobiosis lipoidica diabeticorum”. Int J Dermatol 2008; 47(4): 354-358.

  48. Wake N, Fang JC. “Necrobiosis lipoidica diabeticorum”. Engl J Med 2006; 355: e20.

  49. Fourati M, Marrak H, Fenniche S, Zakraoui H, Zghal M, Khayat O et al. “Necrobiosis lipoidica. Report of 4 cases and review of the literature”. Tunis Med 2003; 81(supl.6): 428-431.

  50. Palamaras I, Kench P, Thomson P, Al-Dulaimi AH, Stevens HP, RoblesW. “An unusual presentation of a common disease”. Dermatol Online J 14: 4.

  51. Requena L, Yus ES. “Panniculitis. Part I. Mostly septal panniculitis”. J Am Acad Dermatol 2001; 45: 163-183, 184-186.

  52. Ullman S, Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  53. Fernandez-Flores A. “Necrobiosis lipoidica and cutaneous anaesthesia: Immunohistochemical study of neural fibres”. Folia Neuropathol 2008; 46(2): 154-157.

  54. Abdulla FR, Sheth PB. “A case of perforating necrobiosis lipoidica in an African American female”. Dermatol Online J 2008; 14(supl. 7): 10.

  55. Falanga V, Eaglstein WH. “Leg and foot ulcers: A clinician’s guide”. 1995; 49-52.

  56. Salomón HJ, Vila FJ, Sales MJM. “Úlceras de las EEII. Diagnóstico diferencial y guía de tratamiento”. Anales de Cirugía Cardiaca y Vascular 2001; 7(4): 253-270.

  57. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. “The clinical spectrum of lipodermatosclerosis”. J Am Acad Dermatol 1993; 28(4): 623-627.

  58. 24.Wee SA, Shupack JL. “Necrobiotic xanthogranuloma”. Dermatol Online J 2005; 11(4): 24.

  59. Gibson LE, Reizner GT, Winkelmann RK. “Necrobiosis lipoidica diabeticorum with cholesterol clefts in the differential diagnosis of necrobiotic xanthogranuloma”. J Cutan Pathol 1988; 15: 18-21.

  60. 26.Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 166: “Erythema Elevatum Diutinum”, consultado el 12 de febrero de 2009 en: http://0-www.accessmedicine.com. millenium.itesm.mx:80/content.aspx?aID=2967488.

  61. Macaron NC, Cohen C, Chen SC, Arbiser JL. “Gli-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum”. Arch Dermatol 2005; 141: 259-262.

  62. Nguyen K, Washenik K, Shupack J. “Necrobiosis lipoidica diabeticorum treated with chloroquine”. J Am Acad Dermatol 2002; 46(2 supl.): S34-S36.

  63. 29.Kreuter A, Knierim C, Stücker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T. “Fumaric acid esters in necrobiosis lipoidica: Results of a prospective noncontrolled study”. Br J Dermatol 2005; 153(4): 802-807.

  64. Cawley EP, Dingman RO. “Necrobiosis lipoidica diabeticorum: Its surgical treatment”. AMA Arch Derm Syphilol 1951; 63(6): 764-767.

  65. Moreno-Arias GA, Camps-Fresneda A. “Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser”. J Cosmet Laser Ther 2001; 3: 143-146.

  66. Darvay A, Acland KM, Russell-Jones R. “Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin”. Br J Dermatol 1999; 141(4): 725-727.

  67. Remes K, Rönnemaa T. “Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment”. J Diabetes Complications 1999; 13(2): 115-118.

  68. De Rie MA, Sommer A, Hoekzema R, Neumann HA. “Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A”. Br J Dermatol 2002; 147(4): 743-747.

  69. Houda H, Soumaya Y, Kahena J, Mohamed RD, Nejib D. “Per fo - rating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: A new case reported”. Dermatol Online J 2008; 14 (supl. 7): 11.

  70. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 152: “Diabetes Mellitus and Other Endocrine Diseases”, consultado el 12 de febrero de 2009 en http://0-www. accessmedicine.com.millenium.itesm.mx:80/content.aspx?aID= 2991346.

  71. Körber A, Dissemond J. “Necrobiosis lipidica diabeticorum”. CMAJ 2007; 177(12): 1498.

  72. Gökdemir G, Sakız D, Kö lü A. “Pyoderma gangrenosum-like presentation of ulcerative necrobiosis lipoidica: Diagnostic and therapeutic challenge”. J Turk Acad Dermatol 2008; 2(1): 82101cpdf.

  73. Arenas R. “Necrobiosis lipoídica”. Atlas. Dermatología, diagnóstico y tratamiento. 3a ed. México, 2005: pp. 195-197.

  74. Imakado S, Satomi H, Iskikawa M, Iwata M, Tsubouchi Y, Otsuka F. “Diffuse necrobiosis lipoidica diabeticorum associated with noninsulin dependent diabetes mellitus”. Clin Exp Dermatol 1998; 23(supl. 6): 271-273.

  75. Wee SA, Possick P. “Necrobiosis lipoidica”. Dermatol Online J 2004; 10(supl. 3): 18.

  76. O’Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. “Necrobiosis lipoidica: Only a minority of patients have diabetes mellitus”. Br J Dermatol 1999; 140(supl. 2): 283-286.

  77. Dandona P, Freedman D, Barter S, Majew BB, Rhodes EL, Waston B. “Glycosylated haemoglobin in patients with necrobiosis lipoidica and granuloma annulare”. Clin Exp Dermatol 1981; 6(3): 299-302.

  78. Cohen O, Yaniv R, Karasik A, Trau H. “Necrobiosis lipoidica and diabetic control revisited”. Med Hypotheses 1996; 46(supl. 4): 348-350.

  79. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L. “Successful treatment of necrobiosis lipoidica with antimalarial agents”. Arch Dermatol 2008; 144(1): 118-119.

  80. Ullman S. Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  81. Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, Rendell M. “Skin blood flow in necrobiosis lipoidica diabeticorum”. Int J Dermatol 2008; 47(4): 354-358.

  82. Wake N, Fang JC. “Necrobiosis lipoidica diabeticorum”. Engl J Med 2006; 355: e20.

  83. Fourati M, Marrak H, Fenniche S, Zakraoui H, Zghal M, Khayat O et al. “Necrobiosis lipoidica. Report of 4 cases and review of the literature”. Tunis Med 2003; 81(supl.6): 428-431.

  84. Palamaras I, Kench P, Thomson P, Al-Dulaimi AH, Stevens HP, RoblesW. “An unusual presentation of a common disease”. Dermatol Online J 14: 4.

  85. Requena L, Yus ES. “Panniculitis. Part I. Mostly septal panniculitis”. J Am Acad Dermatol 2001; 45: 163-183, 184-186.

  86. Ullman S, Dahl MV. “Necrobiosis lipoidica. An immunofluroescence study”. Arch Dermatol 1977; 113: 1671-1673.

  87. Fernandez-Flores A. “Necrobiosis lipoidica and cutaneous anaesthesia: Immunohistochemical study of neural fibres”. Folia Neuropathol 2008; 46(2): 154-157.

  88. Abdulla FR, Sheth PB. “A case of perforating necrobiosis lipoidica in an African American female”. Dermatol Online J 2008; 14(supl. 7): 10.

  89. Falanga V, Eaglstein WH. “Leg and foot ulcers: A clinician’s guide”. 1995; 49-52.

  90. Salomón HJ, Vila FJ, Sales MJM. “Úlceras de las EEII. Diagnóstico diferencial y guía de tratamiento”. Anales de Cirugía Cardiaca y Vascular 2001; 7(4): 253-270.

  91. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. “The clinical spectrum of lipodermatosclerosis”. J Am Acad Dermatol 1993; 28(4): 623-627.

  92. 24.Wee SA, Shupack JL. “Necrobiotic xanthogranuloma”. Dermatol Online J 2005; 11(4): 24.

  93. Gibson LE, Reizner GT, Winkelmann RK. “Necrobiosis lipoidica diabeticorum with cholesterol clefts in the differential diagnosis of necrobiotic xanthogranuloma”. J Cutan Pathol 1988; 15: 18-21.

  94. 26.Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine. Internet. 7a ed. McGraw- Hill, 2008. Cap. 166: “Erythema Elevatum Diutinum”, consultado el 12 de febrero de 2009 en: http://0-www.accessmedicine.com. millenium.itesm.mx:80/content.aspx?aID=2967488.

  95. Macaron NC, Cohen C, Chen SC, Arbiser JL. “Gli-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum”. Arch Dermatol 2005; 141: 259-262.

  96. Nguyen K, Washenik K, Shupack J. “Necrobiosis lipoidica diabeticorum treated with chloroquine”. J Am Acad Dermatol 2002; 46(2 supl.): S34-S36.

  97. 29.Kreuter A, Knierim C, Stücker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T. “Fumaric acid esters in necrobiosis lipoidica: Results of a prospective noncontrolled study”. Br J Dermatol 2005; 153(4): 802-807.

  98. Cawley EP, Dingman RO. “Necrobiosis lipoidica diabeticorum: Its surgical treatment”. AMA Arch Derm Syphilol 1951; 63(6): 764-767.

  99. Moreno-Arias GA, Camps-Fresneda A. “Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser”. J Cosmet Laser Ther 2001; 3: 143-146.

  100. Darvay A, Acland KM, Russell-Jones R. “Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin”. Br J Dermatol 1999; 141(4): 725-727.

  101. Remes K, Rönnemaa T. “Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment”. J Diabetes Complications 1999; 13(2): 115-118.

  102. De Rie MA, Sommer A, Hoekzema R, Neumann HA. “Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A”. Br J Dermatol 2002; 147(4): 743-747.




2020     |     www.medigraphic.com